semaglutide in texas and Tirzepatide Weight Loss Program Houston at Amerejuve MedSpa Semaglutide Prescription for Weight Loss

Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities

The researchers randomly assigned patients to continue their medication as prescribed (n = 28) or to hold one dose of medication before their procedure (n = 32)

Some of the most common or potential side effects include: Nausea Constipation Vomiting Diarrhea Abdominal Pain Headache Indigestion Injection site reactions Dizziness Back pain Increased Lipase or Amylase Altered taste Nasopharyngitis (common cold) Passing Gas Bloating Belching Gastroenteritis Decreased appetite Fatigue Gastroesophageal reflux disease Low blood sugar (hypoglycemia) in those with Type 2 diabetes Upset stomach These symptoms often subside as your body adjusts to the medications

They are thought to work in several ways: Your stomach empties more slowly, so you feel full longer after meals Your brain's hunger centers get signals that can reduce appetite Your blood sugar stays more balanced, which can cut down on cravings In a large clinical trial of FDA-approved semaglutide for chronic weight management (Wegovy), participants on the medication plus diet and exercise lost, on average, around 15% of their body weight over 68 weeks